2D (2 Dimensional) TEQR design for Determining the optimal Dose for safety and efficacy
Article in Contemporary Clinical Trials Communications (October 2019)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Extensions of the mTPI and TEQR designs to include non-monotone efficacy in addition to toxicity for optimal dose determination for early phase immunotherapy oncology trials
Article in Contemporary Clinical Trials Communications (January 2018)
A robust two‐stage design identifying the optimal biological dose for phase I/II clinical trials
Article in Statistics in Medicine (August 2016)